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Amyloidosis is a systemic disease that usually occurs in the gastrointestinal tract or in muscular or adipose
tissue. Primary amyloidosis of the urinary bladder is a rare disease that can mimic bladder cancer on cystoscopic
examination as well as in its clinical presentation of painless gross hematuria. This report describes a 49-
year-old male with repeated painless gross hematuria, who underwent transurethral resection of a suspected
bladder tumor. Pathologic examination revealed papillary urothelial hyperplasia with vascular ectasia and
no signs of malignancy. Massive gross hematuria occurred 2.5 years later. Cystoscopy showed multiple papillary
lesions with yellowish-brown submucosal plaques on the posterior bladder wall. A second transurethral tumor
resection was performed and histologic examination revealed plasma cell infiltration and eosinophilic
amorphous deposits in the subepithelial stroma and vascular wall. The deposits were positive for Congo red
and apple-green birefringence under polarized light examination but negative for Masson’s trichrome stain,
indicating that they were not fibrotic in nature. Hence, the diagnosis of amyloidosis of the urinary bladder
was confirmed. Screening for amyloidosis was negative in other organ systems and the patient has remained
disease-free up to the last follow-up 4 years after the second transurethral resection. Amyloidosis should be
considered in the differential diagnosis of patients with recurrent hematuria who have symptoms characteristic
of bladder cancer but negative pathologic study for malignancy. Correct diagnosis relies on clinical alertness
and the use of a special staining technique during pathologic examination. [ J Formos Med Assoc 2006;105(2):
164–167]
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Amyloidosis is characterized by extracellular de-
posits of the fibrillar protein, amyloid. Primary
amyloidosis of the urinary bladder resembles
urothelial carcinoma of the bladder or urethra on
cystoscopic examination and in its clinical pre-
sentation of gross or microscopic hematuria. Few
cases of this rare condition have been reported.1–4
Amyloid deposits in the bladder may be a primary
disease or a secondary manifestation of systemic
amyloidosis. Diagnosis can be made by histopatho-
logic examination following biopsy or resection of
bladder lesions. This report presents the first case
of primary amyloidosis of the urinary bladder doc-
umented in Taiwan.
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Case Report
A 49-year-old man experienced repeated episodes
of painless gross hematuria within 3 weeks prior
to visiting our clinic in June 1998. His medical his-
tory was unremarkable except for a 10-year history
of essential hypertension with regular medical
control. The patient had no history of smoking
or alcohol intake. Urinalysis showed numerous red
blood cells, a pH of 7.0, trace proteinuria and no
sugar or white blood cell sediment. Other urinaly-
sis parameters were unremarkable. Urine culture
also showed negative results. Voided urine cytolo-
gy series was negative for malignancy. Renal ultra-
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sonography, serum electrolyte and liver enzyme
tests, a hemogram and electrophoresis of serum
protein all had normal findings. As there were no
apparent skin lesions or symptoms, the patient re-
fused further subcutaneous abdominal fat pad
aspiration. After the transurethral resection, no
further episodes of massive gross hematuria were
noted, except for a few episodes of self-limiting
sonography was unremarkable. Urinary bladder
ultrasonography revealed a lesion with an uneven
surface at the left posterior bladder wall. Cysto-
scopy also showed multiple large (up to 2 cm) pap-
illary lesions with covering blood clots on the pos-
terior bladder wall. Biopsy of the lesion showed
plasma cell infiltration and eosinophilic amor-
phous deposits in the subepithelial stroma. Eosi-
nophilic amorphous deposits were also seen in
the vascular wall.
Transurethral resection of the papillary lesions
was performed, which revealed dark-brown con-
tents and recent hemorrhage beneath the mucosa.
Pathologic examination revealed papillary urothe-
lial hyperplasia with vascular ectasia and old hem-
orrhage with no evidence of malignancy. However,
the patient continued to experience intermittent,
painless gross hematuria in the following 2.5 years.
Cystoscopy performed during this period only re-
vealed scar tissue, while biopsies showed urotheli-
al hyperplasia and chronic inflammation. Results
of repeated voided urine cytology tests, excretory
urography and renal ultrasonography were all un-
remarkable.
An episode of massive, painless gross hematu-
ria occurred in January 2001. Cystoscopy revealed
recurrent multiple papillary lesions with blood
clots covering the lateral bladder wall, where dif-
fuse yellowish-brown submucosal plaques with
fragile mucosa were also seen. Transurethral resec-
tion of the lesions was performed for a second time.
Pathologic examination revealed mild urothelial
hyperplasia with underlying amorphous, eosi-
nophilic substance deposition in the stroma and
vascular wall (Figure 1). The deposits were posi-
tive for Congo red and apple-green birefringence
under polarized light examination (Figure 2). The
deposits were not fibrotic in nature, as evidenced
by negative Masson’s trichrome stain. Hence, the
diagnosis of amyloidosis of the urinary bladder was
confirmed. Retrospective review and special stain-
ing of the specimen obtained from the first trans-
urethral resection suggested that severe cauteri-
zation might have masked the correct diagnosis of
amyloidosis. Endoscopy of the upper gastrointes-
tinal tract, colonofibroscopy, abdominal ultra-
Figure 1. (A) Amorphous, eosinophilic amyloid deposits within the bladder’s
submucosal layer (hematoxylin & eosin, × 40). (B) Vascular wall amyloid deposits
(hematoxylin & eosin, × 400). (C) Amyloid deposits in submucosal connective tissue
(hematoxylin & eosin, × 400).
Figure 2. (A) Special stains reveal perivascular deposits (arrow) positive for Congo
red (× 200). (B) Visualization of the specimen under polarized light reveals apple-
green birefringence (arrow) (× 200).
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mild hematuria. Follow-up cystoscopy 48 months
after surgery only revealed uneven bladder muco-
sa with engorged vessels at the previous site of
operation.
Discussion
Systemic amyloidosis is a common condition that
affects various organ systems, including the gas-
trointestinal tract, cardiac and striated muscle and
adipose tissue. While the etiology of amyloidosis
is unknown, several theories suggest a chronic
monoclonal inflammatory response or an immu-
nologic mechanism.5 Systemic amyloidosis is com-
monly associated with chronic granulomatous
disease, multiple myeloma or rheumatoid dis-
ease.6 However, primary amyloidosis can occur
anywhere along the urinary tract and has been
reported in the kidney, renal pelvis, ureters, penis
and even in the seminal vesicles.4,7–9 Primary amy-
loidosis of the bladder is rare, and an initial exam-
ination may be easily confused with urothelial
carcinoma due to a similar clinical presentation of
painless gross hematuria.1–4 Caldamone et al re-
viewed 46 cases of primary localized amyloidosis
of the urinary bladder in 1980.4 There were 20
males and 26 females. The age distribution was
from 28 to 80 years, with a mean age of 53 years.
In all but five cases, the major presenting symp-
tom was painless gross hematuria (80%).4 Find-
ings from cystoscopic examination may also mimic
malignant pathologic findings, as fungating, ery-
thematous, hemorrhagic and, sometimes, papillary
lesions are frequently noted. As in the current case,
endoscopic examination may show amyloid depos-
its as yellowish-brown submucosal plaques. This
case illustrates the typical clinical manifestations
and gross features of primary amyloidosis of the
bladder.
Most patients with focal amyloid deposits in
the bladder can be successfully managed with one
or more transurethral resections.2 Follow-up of
patients is necessary due to the high likelihood of
recurrence. In this case, the patient did not experi-
ence recurrent severe gross hematuria during the 4
years after the second transurethral resection. The
patient’s occasional mild hematuria was success-
fully managed by conservative medical treatment.
Medical regimens that include colchicine, nitro-
furazone and dimethyl sulfoxide as primary or
adjuvant therapy have had variable results.10,11
More aggressive procedures such as cystectomy or
ligation of the internal iliac arteries for massive
hemorrhage control are, at times, necessary.12
Although bladder amyloidosis has been correct-
ly diagnosed by cystoscopy in some reported cases,
definitive diagnosis depends on histopathologic
examination of the biopsy or resected specimen.
Histologic examination shows proteinaceous amor-
phous eosinophilic deposits in the extracellular
spaces. Diagnosis is confirmed by fluorescent
apple-green birefringence after Congo red staining
and visualization of the specimen under polarized
light.4
In conclusion, primary bladder amyloidosis is
a rare cause of painless gross hematuria, and can
have similar cystoscopic features as urothelial
carcinoma. Pathologic examination and special
staining can help to confirm the diagnosis. Con-
servative therapy, such as endoscopic resection, is
usually adequate. Medical treatment with system-
ic or intravesical agents has demonstrated some
benefit in selected patients. Massive hemorrhage
rarely requires a more aggressive approach such
as surgical treatment. An initial diagnosis of blad-
der amyloidosis should prompt an evaluation of
other organ systems, as this could be the first man-
ifestation of a chronic, extensive disease.
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